- Release Date: 03/09/14 12:55
- Summary: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
- Price Sensitive: No
- Download Document 9.71KB
FPH 03/09/2014 12:55 RELINT REL: 1255 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Directors and Officers Relevant Interests A Details of director or officer Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities "i) 21,000 options to acquire ordinary shares ii) 8,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 28 August 2014 Consideration paid from acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not applicable Consideration paid for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place "i) Issue of 21,000 options to acquire ordinary shares ii) Issue of 8,000 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 20 June 2014 A Details of director or officer Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities "i) 80,000 options to acquire ordinary shares ii) 30,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 28 August 2014 Consideration paid for acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not Applicable Consideration paid for disposal Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place "i) Issue of 80,000 options to acquire ordinary shares ii) Issue of 30,000 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 25 June 2014 A Details of director or officer Name of director or officer of public issuer: Paul ANDREASSI Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Quality & Regulatory B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 32,000 options to acquire ordinary shares ii) 12,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial interest Name of registered holder of securities Paul ANDREASSI D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 28 August 2014 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 32,000 options to acquire ordinary shares ii) Issue of 12,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 4 August 2014 A Details of director or officer Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities "i) 80,000 options to acquire ordinary shares ii) 30,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 28 August 2014 Consideration paid from acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not Applicable Consideration received from disposal Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place "i) Issue of 80,000 options to acquire ordinary shares ii) Issue of 30,000 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 20 June 2014 A Details of director or officer Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 52,000 options to acquire ordinary shares ii) 20,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 28 August 2014 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal Not applicable Consideration paid for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 52,000 options to acquire ordinary shares ii) Issue of 20,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 3 September 2014 A Details of director or officer Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 23,000 options to acquire ordinary shares ii) 9,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 28 August 2014 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 23,000 options to acquire ordinary shares ii) Issue of 9,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 11 July 2014 A Details of director or officer Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Michael Grenfell DANIELL D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 4 June 2014 Consideration paid for acquisition $Nil If the relevant interest was disposed of-- Date of cancellation: 4 June 2014 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 160,000 FPH options and issue of 24,320 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 20 December 2013 End CA:00254811 For:FPH Type:RELINT Time:2014-09-03 12:55:06
- Forums
- NZX - By Stock
- Ann: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
Ann: RELINT: FPH: Disclosure of Directors and Officers Relevant...
Featured News
Add FPH (NZSX) to my watchlist
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online